Qiqiang Zhang

1665 Kongjiang Road
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Benzoylaconitine and ginsenoside Rb1 synergistically attenuate cardiac remodeling through dual enhancement of DLG1-dependent mitochondrial integrity.

Benzoylaconitine and ginsenoside Rb1 synergistically attenuate cardiac remodeling through dual enhancement of DLG1-dependent mitochondrial integrity.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 20, 2025

Benzoylaconine Protects Skeletal Muscle Against Ischemia-Reperfusion Injury Through Activation of IF1-Dependent AMPK/Nrf2 Axis.

Benzoylaconine Protects Skeletal Muscle Against Ischemia-Reperfusion Injury Through Activation of IF1-Dependent AMPK/Nrf2 Axis.

Journal: Drug design, development and therapy

Published: December 26, 2023

Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway.

Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway.

Journal: Oxidative medicine and cellular longevity

Published: December 15, 2021

Schisandrin B targets cannabinoid 2 receptor in Kupffer cell to ameliorate CCl4-induced liver fibrosis by suppressing NF-κB and p38 MAPK pathway.

Schisandrin B targets cannabinoid 2 receptor in Kupffer cell to ameliorate CCl4-induced liver fibrosis by suppressing NF-κB and p38 MAPK pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: August 12, 2021

Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer.

Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer.

Journal: Cancer cell international

Published: March 26, 2021

Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer.

Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer.

Journal: Cancer cell international

Published: November 02, 2020

Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma.

Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma.

Journal: Drug design, development and therapy

Published: November 02, 2020

Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy.

Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy.

Journal: BMC complementary medicine and therapies

Published: February 04, 2020

Revealing Synergistic Mechanism of Multiple Components in Gandi Capsule for Diabetic Nephropathy Therapeutics by Network Pharmacology.

Revealing Synergistic Mechanism of Multiple Components in Gandi Capsule for Diabetic Nephropathy Therapeutics by Network Pharmacology.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: December 23, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026